Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Roberts

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Hospital Infection|November 19, 1997
Chlorhexidine gluconate (CHG) activity against clinical isolates of vancomycin-resistant Enterococcus faecium (VREF) and the effects of moisturizing agents on CHG residue accumulation on the skinS W Frantz, K A Haines, C G Azar, et al.
The Journal of Infectious Diseases|July 4, 1998
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study GroupR B Roberts, A de Lencastre, W Eisner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytesH W Murray, D Scavuzzo, J L Jacobs, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. R B Roberts, M Chung, H de Lencastre, et al.
The Pediatric Infectious Disease Journal|June 5, 1998
Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decadesM H Macris, N Hartman, B Murray, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency SyndromeE Wolinsky, C R Horsburgh, D L Cohn, et al.
Diagnostic Microbiology and Infectious Disease|July 14, 1999
Practical approach to the identification of clinically relevant Enterococcus speciesB M Willey, R N Jones, A McGeer, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Hospital Infection|November 19, 1997
Chlorhexidine gluconate (CHG) activity against clinical isolates of vancomycin-resistant Enterococcus faecium (VREF) and the effects of moisturizing agents on CHG residue accumulation on the skinS W Frantz, K A Haines, C G Azar, et al.
The Journal of Infectious Diseases|July 4, 1998
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study GroupR B Roberts, A de Lencastre, W Eisner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytesH W Murray, D Scavuzzo, J L Jacobs, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. R B Roberts, M Chung, H de Lencastre, et al.
The Pediatric Infectious Disease Journal|June 5, 1998
Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decadesM H Macris, N Hartman, B Murray, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency SyndromeE Wolinsky, C R Horsburgh, D L Cohn, et al.
Diagnostic Microbiology and Infectious Disease|July 14, 1999
Practical approach to the identification of clinically relevant Enterococcus speciesB M Willey, R N Jones, A McGeer, et al.
Pageof 13